SWP
GILD icon

Strategic Wealth Partners’s Gilead Sciences GILD Stock Holding History

Strategic Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Sell
205
-17
-8% -$2.24K ﹤0.01% 680
2026
Q1 		$30.9K Buy
222
+7
+3% +$980 ﹤0.01% 611
2025
Q4 		$26.4K Sell
215
-49
-19% -$5.96K ﹤0.01% 639
2025
Q3 		$29.3K Hold
264
– – ﹤0.01% 657
2025
Q2 		$29.3K Buy
+264
New +$28.1K ﹤0.01% 581
2024
Q1 		– Sell
-7,950
Closed -$644K – 293
2023
Q4 		$644K Sell
7,950
-23,534
-75% -$1.83M 0.08% 161
2023
Q3 		$2.36M Sell
31,484
-3,586
-10% -$276K 0.31% 92
2023
Q2 		$2.7M Sell
35,070
-708
-2% -$56.5K 0.35% 88
2023
Q1 		$2.97M Sell
35,778
-1,034
-3% -$85.6K 0.46% 61
2022
Q4 		$3.16M Sell
36,812
-32,495
-47% -$2.57M 0.59% 48
2022
Q3 		$4.28M Sell
69,307
-411
-0.6% -$25.9K 0.91% 22
2022
Q2 		$4.31M Sell
69,718
-2,051
-3% -$127K 0.93% 21
2022
Q1 		$4.27M Sell
71,769
-5,016
-7% -$321K 0.83% 28
2021
Q4 		$5.58M Buy
+76,785
New +$5.29M 1.06% 18
2019
Q4 		– Sell
-2,125
Closed -$46K – 271
2019
Q3 		$46K Buy
2,125
+556
+35% +$36.3K 0.24% 84
2019
Q2 		$105K Buy
1,569
+446
+40% +$29.3K 0.05% 171
2019
Q1 		$74K Buy
1,123
+135
+14% +$8.97K 0.03% 203
2018
Q4 		$68K Sell
988
-56
-5% -$3.91K 0.03% 205
2018
Q3 		$81K Hold
1,044
– – 0.04% 191
2018
Q2 		$74K Sell
1,044
-549
-34% -$38.8K 0.04% 221
2018
Q1 		$120K Sell
1,593
-8,980
-85% -$714K 0.06% 176
2017
Q4 		$773K Buy
+10,573
New +$803K 0.43% 82

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strategic Wealth Partners's GILD Position: Q2 2026 in Review

Strategic Wealth Partners reduced its Gilead Sciences (GILD) stake by 7.7% in Q2 2026, selling an estimated $2.24K and leaving 205 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Strategic Wealth Partners first reported a position in GILD in Q4 2017 and has held it in 22 quarters since. The position peaked at $5.58M in Q4 2021. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Strategic Wealth Partners held 205 shares of Gilead Sciences worth $25.9K as of Q2 2026.
  • Strategic Wealth Partners sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
  • Gilead Sciences made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #680 holding.
  • Strategic Wealth Partners first reported a position in Gilead Sciences in Q4 2017 and has held it in 22 quarters since.
  • Strategic Wealth Partners's Gilead Sciences position peaked at $5.58M in Q4 2021.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.